Combined light chain immunofixation to detect monoclonal gammopathy: A comparison to standard electrophoresis in serum and urine

Clinical Chemistry and Laboratory Medicine

Volumn 52, Issue 7, 2014, Pages 981-987

  Jenner, Wessel ^a   Klingberg, Sandra ^a   Tate, Jill R ^a   Wilgen, Urs ^a,b   Ungerer, Jacobus P J ^a   Pretorius, Carel J ^a,b  

^a Department of Chemical Pathology Herston Hospitals Campus ^*  (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Amyloidosis; Immunofixation electrophoresis; Monoclonal gammopathy of uncertain significance (mgus); Monoclonal immunoglobulin; Myeloma; Plasma cell proliferative disorder; Protein electrophoresis

Indexed keywords

ANTISERUM; OLIGOCLONAL BAND; PARAPROTEIN; REAGENT; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN;

ARTICLE; CLINICAL EVALUATION; COMBINED LIGHT CHAIN IMMUNOFIXATION; CONTROLLED STUDY; COST CONTROL; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HUMAN; IMMUNOFIXATION ELECTROPHORESIS; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; PRIORITY JOURNAL; PROTEIN ELECTROPHORESIS; SENSITIVITY ANALYSIS; SERUM; URINE; BLOOD; COMPARATIVE STUDY; IMMUNOELECTROPHORESIS; PARAPROTEINEMIAS;

BLOOD PROTEIN ELECTROPHORESIS; FEMALE; HUMANS; IMMUNOELECTROPHORESIS; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LAMBDA-CHAINS; MALE; PARAPROTEINEMIAS;

EID: 84903703219     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2014-0023     Document Type: Article

References (9)

1. Dimopoulos M, Kyle R, Fermand J, Rajkumar SV, San Miguel J, Chanan-Khan A, et al. on behalf of the International Myeloma Workshop Consensus Panel 3.Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3. Blood 2011;117:4701-5.
2. Tate JR, Caldwell G, Daly J, Gillis D, Jenkins M, Jovanovich S, et al. on behalf of the working party on standardised reporting of protein electrophoresis. Recommendations for standardized reporting of protein electrophoresis in Australia and New Zealand. Ann Clin Biochem 2012;49:242-56.
3. Katzmann JA, Kyle RA, Benson J, Larson DR, Snyder MR, Lust JA, et al. Screening panels for detection of monoclonal gammopathies. Clin Chem 2009;55:1517-22.
4. Fulton RB, Fernando SL. Serum free light chain reduces the need for serum and urine immunofixation electrophoresis in the evaluation of monoclonal gammopathy. Ann Clin Biochem 2009;46:407-12.
5. Wadhera RK, Rajkumar V. Prevalence of monoclonal gammopathy of undetermined significance: A systemic review. Mayo Clin Proc 2010;85:933-42.
6. Kyle RA, Therneau TM, Rajkumar V, Larson MS, Plevak MF, Offord JR, et al. Prevalence of monoclonal gammopathy of undertermined significance. N Engl J Med 2006;354:1362-9.
7. Eisele L, Dürig J, Hüttmann A, Dührsen U, Assert R, Bokhof B, et al. on behalf of the Heinz Nixdorf Recall study investigative group. Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany. Ann Hematol 2012;91:243-8.
8. Altman DG, Machin D, Bryant TN, Gardner MJ. Statistics with confidence. 2nd ed. London: BMJ Books, 2000.
9. Rang M. The Ulysses syndrome. Can Med Assoc J 1972;106:122-3.